Arrival of CAR-T Immunotherapy Raise Hopes for Treatment and Anxieties About Costs – Cancer Therapy Advisor
Cancer Therapy AdvisorArrival of CAR-T Immunotherapy Raise Hopes for Treatment and Anxieties About CostsCancer Therapy AdvisorIn the phase 2 trial of 63 patients upon which FDA approval was based, CTL019 boasted a remarkable 83% overall remission rate,… Continue reading
